Investor Contact: Ana Kapor Portola Pharmaceuticals email@example.com Media Contact: Julie Normart W2O Group firstname.lastname@example.org
Without at least one approved drug, I am tempted to say you should just take a pass.
Jim Cramer says do your homework, be informed and don't let the wise guys trip you up with their warnings about 'single-stock risk.'
A look at Jim Cramer's thoughts on stocks of interest to "Mad Money" viewers.
Earnings and Fed speakers are on tap in the next few days.